{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-010520","form_type":"8-K","ticker":"HROW","cik":"0001360214","company_name":"HARROW, INC.","filed_at":"2024-03-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.947531+00:00","generated_at":"2026-06-04T13:07:53.320515+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Harrow full-year 2023 revenue $130.2M (+47% YoY), GAAP net loss widens to $24.4M; adj EBITDA $28.1M","bullets":["FY2023 revenue $130.2M, up 47% YoY; GAAP net loss $24.4M (vs $14.1M loss in 2022).","Adjusted EBITDA $28.1M, +116% YoY; cash from ops $3.8M full-year, $8.7M in Q4.","IHEEZO Q4 reorder rate 83%; Q1 2024 sales impacted by Change Healthcare cyberattack; CMS added J-code to ASP file.","VEVYE launch exceeding expectations; 70% refill rate; over 40M covered lives including TriCare and Aetna.","TRIESENCE first PPQ batch scheduled for April 15; NDA transferred; price set at $944/unit; targeting 90K units inventory."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-010520","json":"https://secwatch.observer/filing/0001493152-24-010520.json","markdown":"https://secwatch.observer/filing/0001493152-24-010520.md","text":"https://secwatch.observer/filing/0001493152-24-010520.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1360214/000149315224010520/0001493152-24-010520-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1360214/000149315224010520/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T13:07:53.320515+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c14ceca0aa4554393f58ae78a4304f52839e4fd6","claim":"HARROW, INC. reported the year and quarter ended December 31, 2023 results: revenue $130,193,000, net income $(24,411,000), EPS $(0.75).","evidence_excerpt":"Form 8-K. --- EX-99.1 () --- EX-99.1 2 ex99-1.htm Exhibit 99.1 Harrow Announces Fourth Quarter and Year-End 2023 Financial Results Full-Year 2023 Highlights: ● Revenues of $130.2 million, an increase of 47% over 2022 revenues of $88.6 million. ● GAAP net loss of $(24.4 million) compared with $(14.1 million) for the prior-year period. ● Adjusted EBITDA of $28.1","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1360214/000149315224010520/0001493152-24-010520-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the year and quarter ended December 31, 2023"},{"label":"Revenue","value":"$130,193,000"},{"label":"Net income","value":"$(24,411,000)"},{"label":"EPS","value":"$(0.75)"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}